The present study demonstrated that the administration of CANA significantly ameliorated PRMD induced by cardiac arrest and CPR with decreased myocardial injury score, increased MAP, decreased levels of cTnI and NT-ProBNP. The gene discussed is TNNI3; the disease is cardiac arrest.